Arlington Capital Partners (Arlington), a Washington, D.C.-area private investment firm specializing in government-regulated industries, has acquired TEAM Technologies (TEAM Tech), a leading global manufacturer of essential healthcare products, from Clearlake Capital Group (Clearlake).

TEAM Tech is a provider of specialized manufacturing and strategic supply chain solutions to blue-chip healthcare customers. The company provides a broad array of end-to-end outsourced design and manufacturing services to medical device and pharmaceutical OEMs. TEAM Tech also has a growing specialty in advanced medical devices that are critical to the healthcare system.

“The medical device manufacturing industry is incredibly complex, but we feel fortunate to partner with Arlington in our next chapter,” said Marshall White, CEO of TEAM Tech. “I have gotten to know Matt and the Arlington team well over the past several years and believe that with their 25 years of experience in this highly regulated sector, they are best positioned to help us build on the successes we have achieved and accelerate our growth, both organically and through strategic acquisitions, to take our business to the next level.”

“As the last five years have demonstrated, global supply chains are not nearly as fortified as they need to be, particularly in medical device manufacturing,” said Matt Altman, a Managing Partner at Arlington Capital Partners. 

TEAM Tech enables customers to streamline their supply chains and reduce lead times in delivering critical products through its suite of vertically integrated processes. TEAM Tech has approximately 1,000,000 square feet of manufacturing space across nine campuses in the U.S., Mexico, and Singapore.

Gordon Auduong, an Arlington Principal added, “As one of the leading end-to-end providers in this sector, we look forward to working with TEAM Tech’s management team and building on its strong foundation to continue adding capabilities and customers, both through organic investment and strategic acquisitions.”

Arlington has an extensive track record of building leading companies in the healthcare sector. Recent investments include Afton Scientific, AVS Bio, Millstone Medical Outsourcing, Riverpoint Medical, and Grand River Aseptic Manufacturing.